Rush University Medical Center has new restrictions regarding visitors and is adjusting non-urgent scheduled appointments. For information about COVID-19, see the latest updates and our FAQs. Rush accepts donations to support systemwide response efforts, frontline staff, and patients and families.

Excellence is just the beginning.


French German Italian Portuguese Russian

The aV1ation Study

Clinical Trial Title: 
The aV1ation study.
Clinical Trial Protocol ID: 
Clinical Trial Investigator Name: 
Soo J. Lee, MD
Clinical Trial Protocol Description: 

People with autism spectrum disorder (ASD) often suffer from secondary conditions too (such as sleeping problems, anxiety and attention issues). Although there are medications available to help manage such secondary conditions, we’ve yet to find any that address the social and communication skill issues at the heart of autism. The aV1ation study will test an investigational medicine that blocks a hormone receptor in the brain linked to the control of socialization, stress, anxiety and aggression.

Clinical Trial Eligibility Criteria: 

In order to participate you must meet the following criteria:

  • Are between the ages of 5 and 17 years old and have a parent/caregiver.
  • Have a diagnosis of autism spectrum disorder.
  • Speak and understand English.
  • Talk in full sentences.

This is a partial list of elgibility requirements.

Clinical Trial Area: 
Autism Spectrum Disorders
Contact Phone: 
(312) 563-3352
Contact Name: 
Madison Printen